KITE PHARMA INC (KITE): Free Stock Analysis Report GILEAD SCIENCES INC (GILD): Free Stock Analysis ReportĬAMBREX CORP (CBM): Free Stock Analysis ReportĬHINA BIOLOGIC PRODUCTS INC (CBPO): Free Stock Analysis Report Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. All three sport a Zacks Rank #1 (Strong Buy). Other better-ranked stocks in the biomedical/gene industry include Gilead Sciences Inc. Kite Pharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future. In the last 30 days, the company witnessed a positive estimate revision while the Zacks Consensus Estimate moved lower, signaling trouble down the road. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $21.52 to $23.83 in the past one-month timeframe. The move came on solid volume too with far more shares changing hands than in a normal session. ( KITE) was a big mover last session, as its shares rose almost 18% on the day.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |